AbbVie (NYSE: ABBV) announced it will present data from its multiple myeloma research portfolio at the 23rd International Myeloma Society ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE